Matinas BioPharma
in dose dependent knockdown of a in murine cells | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
26 of 31
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical identified as rescuing cells treated with insight from rescued loss of | Recursion Pharmaceuticals
Apexigen
Investor Presentation
September 2022
single dose of turns cold tumor hot data presented at some | Apexigen
Alkermes
Investor Day
March 2021
demonstrated dose dependent increases in exposure and wakefulness pharmacodynamics strong relationship demonstrated in rat model suggests potential for low human dose did not adversely elevate heart rate and blood pressure in a rat hemodynamic model at pharmacologically relevant plasma exposures alkermes data on file time time | Alkermes
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights